Page 1373 - Veterinary Immunology, 10th Edition
P. 1373

killer (NK) cells and some antibody-dependent cellular cytotoxicity
  VetBooks.ir  (ADCC) reactions may be refractory to corticosteroid treatment. In

               cattle, corticosteroids may increase serum interferon levels. The
               effects of corticosteroids on antibody responses are variable and

               depend on timing and dose. In general, B cells tend to be
               corticosteroid resistant, and enormous doses are usually required to
               suppress antibody synthesis. It is interesting to note, however, that
               in horses, moderate doses of dexamethasone suppress IgG1 and

               IgG4 responses while having no apparent effect on IgG3 responses.
               Corticosteroids also upregulate the expression of CD121b. This is a
               decoy receptor that can bind active IL-1 but will not transduce a
               signal, effectively blocking IL-1 activity.

                  Synthetic corticosteroids suppress acute inflammation. They
               inhibit increased vascular permeability and vasodilation and thus
               prevent edema formation and fibrin deposition. At the same time,
               they block the emigration of leukocytes from capillaries. They

               inhibit the release of lysosomal enzymes and impair antigen
               processing by macrophages. Corticosteroids can also inhibit
               phospholipases and so prevent the production of leukotrienes and
               prostaglandins. In the later stages of inflammation, they inhibit

               capillary and fibroblast proliferation (perhaps by blocking IL-1
               production) and enhance collagen breakdown. As a result,
               corticosteroids delay wound and fracture healing.
                  When systemic corticosteroid therapy is initiated, prednisolone

               or methylprednisolone are usually the agents selected for small
               animal treatment, and betamethasone and dexamethasone are
               commonly employed in large animal practice. Cats may require
               significantly higher doses than dogs to achieve a significant clinical

               response. This treatment is not without risks since it has the
               potential to suppress the pituitary-adrenal axis and induce
               Cushing's syndrome. By suppressing inflammation and
               phagocytosis, corticosteroids may render animals highly

               susceptible to infection. Once a response has been induced,
               therefore, the dose of corticosteroids should be gradually reduced
               by lengthening the dose interval and then decreasing the amount
               given (Box 41.2).









                                                        1373
   1368   1369   1370   1371   1372   1373   1374   1375   1376   1377   1378